Biotechnology
Biopharmaceutical
Pharmaceutical

Ziopharm Oncology

$4.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.24%) Today
+$0.00 (0.12%) After Hours

Why Robinhood?

You can buy or sell ZIOP and other stocks, options, ETFs, and crypto commission-free!

About

ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. Read More The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Employees
48
Headquarters
Boston, Massachusetts
Founded
2003
Market Cap
686.47M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.62M
High Today
$4.39
Low Today
$4.18
Open Price
$4.28
Volume
415.94K
52 Week High
$5.00
52 Week Low
$1.56

Collections

Biotechnology
Biopharmaceutical
Pharmaceutical
Cancer Prevention
Health
Therapy
Technology
US

News

Seeking AlphaMay 8

ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2019 Results - Earnings Call Transcript

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Christopher Taylor - VP, IR David Mauney - President Laurence Cooper - CEO & Director Conference Call Participants Reni Benjamin - Raymond James & Associates Eric Joseph - JPMorgan Chase & Co. Swayampakula Ramakanth - H.C. Wainwright & Co. I-Eh Jen - Laidlaw & Company Thomas Flaten - Lake Street Capital Markets Operator Good afternoon, ladies and gentlemen, and welcome to the Ziopha...

167
Yahoo FinanceMay 8

ZIOPHARM Oncology, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 8, 2019 / ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-D0C85F04B79EE To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile. About Investor Network...

64
Yahoo FinanceMay 1

Ziopharm Oncology to Host Conference Call to Discuss First Quarter 2019 Financial Results on May 8, 2019

BOSTON, May 01, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (ZIOP) today announced that management will host a conference call and webcast on Wednesday, May 8, at 4:30 p.m. ET to provide a corporate update and discuss financial results for the first quarter ended March 31, 2019. The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international). The passcode for the conference call is 9185154. To access the live webcast or the subsequent archived recording, visit...

115

Earnings

-$0.15
-$0.13
-$0.10
-$0.08
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.